Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications.
about
WITHDRAWN: Diclofenac for acute pain in children.Diclofenac for acute pain in childrenDiclofenac for acute pain in childrenClinical Pharmacokinetics of Penicillins, Cephalosporins and Aminoglycosides in the Neonate: A Review.Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery.An update on sodium valproate.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.Preliminary studies on the disposition of meptazinol in the neonate.Routes of meptazinol conjugation in the neonateDecreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels.Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates.Children versus adults: pharmacokinetic and adverse-effect differences.Differences between children and adults: implications for risk assessment at California EPA.Pharmacokinetics in the infant.Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndromePharmacokinetics of dapsone in human immunodeficiency virus-infected children.Continuous intravenous infusion of ampicillin and gentamicin during parenteral nutrition in 88 newborn infants.Disposition of antineoplastic agents in the very young childTolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.Children's susceptibility to chemicals: a review by developmental stage.Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease.Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations.Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3.Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation.ATSDR evaluation of the health effects of zinc and relevance to public health.ATSDR evaluation of health effects of benzene and relevance to public health.Acrolein health effects.Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and AdultsNeonatal seizures: diagnosis and treatment.Are rats the appropriate experimental model to understand age-related renal drug metabolism and toxicity?Pediatric drug development: formulation considerations.Practical pharmacokinetics: what do you really need to know?Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.Safety considerations of anesthetic drugs in children.Prescribing for infants and children.Measurement of the renal clearance of drugs.Clinical pharmacology. Elimination of drugs.Bioavailability of intramuscular vitamin E acetate in rabbits.Lorazepam toxicity in a premature infant.
P2860
Q24186675-B4D3D9B3-816E-4DD2-9DCC-F6784580DFF1Q24240354-A0DB1EB6-9AFF-4B2E-AA1F-0D129F019C0BQ24246170-8BFFF7F5-0A28-459B-A15A-5E6C0E73BB7EQ30437952-9EA2BF2C-5A3D-4EED-8072-0FF35FE007C5Q31805892-E8B755C3-79BD-4CD0-A83F-C38CA12BDEB0Q33797920-DE126D0B-58B1-415F-879E-54692A1576B9Q34195505-BDD242C4-66DB-40ED-A19A-88FBB364B78BQ34342674-2FB8492B-14D7-4E17-82F8-F4AC9B2E17D2Q34448930-A7F639AB-E2A8-40B1-A66B-3F1245381FD2Q34511293-370F0269-3BD9-4960-98E7-79E0D1308CD8Q34620875-7DE467D5-C3BF-4C3C-9D48-8C3D4A210B99Q34646349-E9D16040-5C80-47FB-82A4-C9C376558FB4Q34680689-30466EE2-8E02-4A2B-B3FE-EC887F69F025Q34978971-6FE41DD5-BBD2-4959-A2F9-9E6F38CFF901Q35030831-FD773B57-91C4-486E-9A05-BA2DD0305CDBQ35075945-05F30CC4-9EF4-48B4-88F7-3ADA4950D07DQ35114401-340141A6-2AA5-41D8-B2E0-FCE224491EC1Q35116159-A14AA8D1-5A8A-42FE-A260-D734E9B82525Q35708424-B6E2A477-5E2E-4341-B9DF-621C940B241BQ35765718-3F1815FB-21C8-45BF-B54F-2829D2F918D6Q35977793-CA1C2D02-7C14-4149-8573-0B272BDB2F21Q36053789-6EC34E24-0D62-41EF-A36A-8E6520995D15Q36544972-4F1E901E-1651-4E6D-9AEC-E7FAC888DC7CQ36545025-A2819748-7744-48B4-B15D-A909A4152DB1Q36662879-E986AAC9-AC79-4A9E-8F1B-7CCF948D8F7BQ36833626-1EAB7DBE-7781-43D4-84ED-38EB0AC5FFEDQ37331135-3CBAA41C-E171-4666-8D0F-4203EECCCAF6Q37333260-1951841B-EC68-4F73-A4B9-E21E6BC18717Q37378093-AADA765D-79C2-4025-BEF0-D8DB55F8A675Q37747746-48C11D73-F95D-4E76-A941-4D7C58DC8CD7Q37808477-F1228077-7FFF-4529-98BB-30451137F909Q38183868-D78AE462-9881-41B6-BDE5-AB5F435C63B0Q38239786-3049BD69-B0DA-4DE3-8F33-278E397AA1F4Q39004656-21D053E6-32F4-4493-9093-8870124D789AQ39170303-190EB45A-4B83-4222-B7FD-4902BD4A9A4BQ39602251-AC7CE0BD-4E73-42B7-9A9E-D9200C253E88Q40329525-DAC0BFD2-AD09-449C-AECA-C88F0816F492Q41745793-93094936-0302-44B2-BB4B-954225FD4140Q41765704-D95BC961-5DFF-4B37-A8C6-1C61C06CEBD7Q42287930-08F225FE-B3FE-4FCB-B9EC-8A7128AF7584
P2860
Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Clinical pharmacokinetics in n ...... and therapeutic implications.
@en
type
label
Clinical pharmacokinetics in n ...... and therapeutic implications.
@en
prefLabel
Clinical pharmacokinetics in n ...... and therapeutic implications.
@en
P2093
P1476
Clinical pharmacokinetics in n ...... and therapeutic implications.
@en
P2093
Franco-Morselli R
Morselli PL
P304
P356
10.2165/00003088-198005060-00001
P577
1980-11-01T00:00:00Z
P6179
1050005274